Third, in vitro treatment of PBMC with agonist anti-Fas mAb, but not antagonist anti-Fas mAb, was able to trigger apoptosis and restore the selective defect in HAM/TSP patients. The gene discussed is FAS; the disease is tropical spastic paraparesis.